Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis.

  • 2018-08-21
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 35(1)
    • Maryam Molaie
    • Behrad Darvishi
    • Zahra Jafari Azar
    • Mahboobeh Shirazi
    • Gholamreza Amin
    • Shima Afshar

Study Design

Type
Randomized Controlled Trial (RCT)
Sample size
n = 46
Population
46 women aged between 40 and 60 years experiencing an average of more than four hot flashes per day
Methods
8 week, double-blind, randomized, placebo-controlled study; herbal medication or placebo capsules administered once daily in morning
Blinding
Double-blind
Duration
8 weeks
The goal of the current study was to evaluate the efficiency of a phytotherapeutic intervention consisting of a combination of Nigella sativa and Vitex agnus-castus with citalopram in the control of hot flashes in healthy menopausal women. An 8 week, double-blind, randomized, placebo-controlled study was performed among 46 women aged between 40 and 60 years experiencing an average of more than four hot flashes per day recruited during July 2016 to June 2017. Data on severity of vasomotor symptoms were collected at the end of the eighth week. Herbal medication or placebo capsules were administered once daily in morning. At the end of the 8-week treatment period, analyses of covariance demonstrated the superiority of herbal combination with citalopram over placebo and citalopram for three MENQOL domain scores including vasomotor (p < .001), physical (p = .036), psychosocial (p = .001) but no significant differences were observed in terms of sexual function (p = .231). Based on the results, the addition of a combination of N. sativa and V. agnus-castus to the citalopram may be a potential clinical application for improving therapeutic outcomes. Larger randomized, controlled trials are also warranted for further investigations of these symptoms.

Research Insights

  • analyses of covariance demonstrated the superiority of herbal combination with citalopram over placebo and citalopram for three MENQOL domain scores including … physical (p = .036)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    once daily in morning (dose not specified)
  • analyses of covariance demonstrated the superiority of herbal combination with citalopram over placebo and citalopram for three MENQOL domain scores including … psychosocial (p = .001)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    once daily in morning (dose not specified)
  • no significant differences were observed in terms of sexual function (p = .231)

    Effect
    Neutral
    Effect size
    Small
    Dose
    once daily in morning (dose not specified)
  • analyses of covariance demonstrated the superiority of herbal combination with citalopram over placebo and citalopram for three MENQOL domain scores including vasomotor (p < .001)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    once daily in morning (dose not specified)
  • analyses of covariance demonstrated the superiority of herbal combination with citalopram over placebo and citalopram for three MENQOL domain scores including … physical (p = .036)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    once daily in morning (dose not specified)
  • analyses of covariance demonstrated the superiority of herbal combination with citalopram over placebo and citalopram for three MENQOL domain scores including … psychosocial (p = .001)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    once daily in morning (dose not specified)
  • no significant differences were observed in terms of sexual function (p = .231)

    Effect
    Neutral
    Effect size
    Small
    Dose
    once daily in morning (dose not specified)
  • analyses of covariance demonstrated the superiority of herbal combination with citalopram over placebo and citalopram for three MENQOL domain scores including vasomotor (p < .001)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    once daily in morning (dose not specified)
Back to top